stockrow
Friday 6 November 2026
Export LFMD’s income statement to Excel — free account
LifeMD, Inc.
LFMD Healthcare Health Information Services
LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024.
- Revenue
- −3.55%
- EPS
- −166.7%
- Free cash flow
- −247.5%
Quarter to June 2026, against a year earlier
2.36
0.07
+3.06%
Follow LFMD
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 13.12 | 72.20 | 0.00 |
P/S ratio |
1.88 | 0.79 | 0.88 | 1.03 | |
P/FCF ratio |
101.82 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(2,130.84) | (46.91) | 384.35 | (28.50) | |
P/B ratio |
93.07 | 6.65 | 11.36 | 24.77 | |
Price to Tangible BV |
173.20 | 6.72 | 11.54 | 25.41 | |
EV/Sales |
1.83 | 0.68 | 0.79 | 0.98 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
24.15 | 16.01 | 26.85 | (18.94) | |
EV/FCF |
99.12 | (106.73) | (38.76) | (10.27) | |
Quick Ratio |
0.58 | 1.11 | 0.89 | 0.78 | |
Current Ratio |
0.73 | 1.25 | 1.04 | 0.90 | |
Net Debt/EBITDA |
(7.77) | 11.03 | 4.97 | 4.94 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
2.41 | 2.65 | 2.69 | 2.87 | |
Operating CF/Net income |
0.03 | (0.17) | (0.05) | 0.88 | |
Capex/Depreciation |
(1.06) | (0.55) | (1.03) | (0.80) | |
Interest Coverage |
(7.50) | (3.42) | 158.04 | — | |
Research and Development Expense of Revenue |
4.73% | 2.41% | 3.58% | 3.79% | |
Selling, General and Administrative Expense of Revenue |
76.55% | 72.83% | 89.81% | 88.16% | |
Intangible Assets out of Total Assets |
0.02 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
5.31% | 7.81% | 2.89% | 1.67% | |
Graham Net Nets |
(0.07) | 0.03 | (0.02) | (0.05) | |
Graham Number |
0.00 | 1.73 | 0.60 | 0.00 | |
Earnings Yield |
(4.20%) | 7.62% | 1.39% | (1.21%) | |
Free Cash Flow Yield |
0.98% | (0.81%) | (2.29%) | (9.26%) | |
Revenue per Share |
1.30 | 0.75 | 1.06 | 0.99 | |
Operating CF per Share |
0.00 | (0.07) | 0.01 | (0.14) | |
Capex per Share |
(0.12) | 0.01 | (0.04) | (0.03) | |
Free Cash Flow per Share |
(0.12) | (0.06) | (0.03) | (0.18) | |
Cash per Share |
0.52 | 0.82 | 0.73 | 0.53 | |
Shareholders Equity per Share |
0.07 | 0.51 | 0.32 | 0.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.07 | 0.51 | 0.32 | 0.17 | |
Free Cash Flow |
(5.47) | (2.64) | (1.61) | (8.56) | |
Working Capital |
(15.58) | 10.26 | 2.11 | (4.52) | |
Capital Expenditures |
(5.32) | 0.64 | (2.06) | (1.63) | |
Net Current Asset Value |
(21.53) | 4.58 | (3.39) | (9.84) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.09 | (0.02) | 0.04 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
7.65 | 9.88 | 10.02 | 9.29 | |
Average Payables |
17.71 | 12.53 | 18.67 | 21.22 | |
Average Inventory |
3.04 | 2.79 | 3.07 | 3.10 | |
Average Assets |
69.27 | 73.25 | 71.87 | 66.73 | |
Average Common Equity |
(1.29) | 7.80 | 7.32 | 4.17 |
Columns are period end dates · fundamentals updated 26 Oct 2026